 |
|
Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases
Eugene Han (Han E), Yong-ho Lee (Lee Yh)
Diabetes Metab J. 2017;41(6):430-437. Published online 2017 Nov 17 DOI: https://doi.org/10.4093/dmj.2017.41.6.430
|
|
Citations to this article as recorded by
 Emerging Role of Protein O-GlcNAcylation in Liver Metabolism: Implications for Diabetes and NAFLD
Ziyan Xie, Ting Xie, Jieying Liu, Qian Zhang, Xinhua Xiao
International Journal of Molecular Sciences.2023; 24(3): 2142. CrossRef A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome
Eun Ran Kim, Jeong Su Park, Jin Hee Kim, Ji Young Oh, In Jeong Oh, Da Hyun Choi, Yu seol Lee, I. Seul Park, SeungWon Kim, Da Hyun Lee, Jae Hee Cheon, Jin‐Woo Bae, Minyoung Lee, Jin Won Cho, In Bok An, Eun Joo Nam, Sang‐In Yang, Myung‐Shik Lee, Soo Han Bae
Hepatology.2022; 75(6): 1523. CrossRef Analysis of Severe Hypoglycemia Among Adults With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Ji-Yeon Lee, Young-eun Kim, Kyungdo Han, Eugene Han, Byung Wan Lee, Eun Seok Kang, Bong-Soo Cha, Seung-Hyun Ko, Yong-ho Lee
JAMA Network Open.2022; 5(2): e220262. CrossRef State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic Steatohepatitis
Yongin Cho, Yong-ho Lee
Endocrinology and Metabolism.2022; 37(1): 38. CrossRef Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
Iresha Sandamali Koralegedara, Janith Niwanthaka Warnasekara, Ashani Rathnayake, Korale Gedara Dayaratne, Suneth Buddhika Agampodi
BMJ Open Gastroenterology.2022; 9(1): e000913. CrossRef A Prediction Model of the Incidence of Nonalcoholic Fatty Liver Disease With Visceral Fatty Obesity: A General Population-Based Study
Yang Zhou, Xiangping Chai, Tuo Guo, Yuting Pu, Mengping Zeng, Aifang Zhong, Guifang Yang, Jiajia Cai
Frontiers in Public Health.2022;[Epub] CrossRef Non-alcoholic fatty liver disease and sarcopenia is associated with the risk of albuminuria independent of insulin resistance, and obesity
Eugene Han, Mi Kyung Kim, Seung-Soon Im, Byoung Kuk Jang, Hye Soon Kim
Journal of Diabetes and its Complications.2022; 36(8): 108253. CrossRef Increased Risk of NAFLD in Adults with Glomerular Hyperfiltration: An 8-Year Cohort Study Based on 147,162 Koreans
Dae-Jeong Koo, Mi Yeon Lee, Inha Jung, Sun Joon Moon, Hyemi Kwon, Eun-Jung Rhee, Cheol-Young Park, Won-Young Lee, Ki Won Oh, Se Eun Park
Journal of Personalized Medicine.2022; 12(7): 1142. CrossRef Effects of Avocado Oil Supplementation on Insulin Sensitivity, Cognition, and Inflammatory and Oxidative Stress Markers in Different Tissues of Diet-Induced Obese Mice
Schérolin de Oliveira Marques, Alexandre Pastoris Muller, Thais Fernandes Luciano, Natália dos Santos Tramontin, Mateus da Silva Caetano, Bruno Luis da Silva Pieri, Tatiane Lima Amorim, Marcone Augusto Leal de Oliveira, Cláudio Teodoro de Souza
Nutrients.2022; 14(14): 2906. CrossRef Relationship Between Handgrip Strength and Laboratory Values in Adolescents With Non-Alcoholic Fatty Liver Disease
Si Yeong Lee, Yong Whi Jeong, Hong Koh, Yunkoo Kang
Journal of Clinical Densitometry.2022; 25(4): 490. CrossRef Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns
Liu Lei, Wang Changfa, Wang Jiangang, Chen Zhiheng, Yuan Ting, Zhu Xiaoling, Deng Yuling, Wang Yaqin
Scientific Reports.2022;[Epub] CrossRef
Muscle fat contents rather than muscle mass determines
nonal
coholic steatohepatitis and liver fibrosis in patients with severe obesity
Eugene Han, Mi Kyung Kim, Hye Won Lee, Seungwan Ryu, Hye Soon Kim, Byoung Kuk Jang, Youngsung Suh
Obesity.2022; 30(12): 2440. CrossRef Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based study
Akira Mima
Scientific Reports.2022;[Epub] CrossRef Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease
Mehmet Kanbay, Mustafa C. Bulbul, Sidar Copur, Baris Afsar, Alan A. Sag, Dimitrie Siriopol, Masanari Kuwabara, Silvia Badarau, Adrian Covic, Alberto Ortiz
Journal of Nephrology.2021; 34(3): 649. CrossRef Taxifolin ameliorate high-fat-diet feeding plus acute ethanol binge-induced steatohepatitis through inhibiting inflammatory caspase-1-dependent pyroptosis
Zi-Ying Zhan, Mei Wu, Yue Shang, Min Jiang, Jian Liu, Chun-Ying Qiao, Huan Ye, Yong-Ce Lin, Mei-Hua Piao, Rong-Hui Sun, Zhi-Hong Zhang, Jing-Ya Jiao, Yan-Ling Wu, Ji-Xing Nan, Li-Hua Lian
Food & Function.2021; 12(1): 362. CrossRef Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
Eugene Han, Mi Kyung Kim, Byoung Kuk Jang, Hye Soon Kim
Diabetes & Metabolism Journal.2021; 45(5): 698. CrossRef The Leg Fat to Total Fat Ratio Is Associated with Lower Risks of Non-Alcoholic Fatty Liver Disease and Less Severe Hepatic Fibrosis: Results from Nationwide Surveys (KNHANES 2008–2011)
Hyun Min Kim, Yong-ho Lee
Endocrinology and Metabolism.2021; 36(6): 1232. CrossRef A preliminary report about the detection of ventricular repolarisation in patients with non-alcoholic fatty liver disease
Marwan S. Al-Nimer, Vian A. Esmail, Dler S. Hamid, Mohammad O. Mohammad
Journal of Taibah University Medical Sciences.2020; 15(4): 284. CrossRef Atorvastatin attenuates obese-induced kidney injury and impaired renal organic anion transporter 3 function through inhibition of oxidative stress and inflammation
Nattavadee Pengrattanachot, Rada Cherngwelling, Krit Jaikumkao, Anchalee Pongchaidecha, Laongdao Thongnak, Myat Theingi Swe, Varanuj Chatsudthipong, Anusorn Lungkaphin
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.2020; 1866(6): 165741. CrossRef Correlation Between Non-Alcoholic Fatty Liver and Chronic Kidney Disease
Hasyim Kasim, St. Rabiul Zatalia, Haerani Rasyid, Syakib Bakri, Muhammad L. Parewangi, Fardah Akil, Arifin Seweng
The Open Urology & Nephrology Journal.2020; 13(1): 1. CrossRef Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
Byung-Wan Lee, Yong-ho Lee, Cheol-Young Park, Eun-Jung Rhee, Won-Young Lee, Nan-Hee Kim, Kyung Mook Choi, Keun-Gyu Park, Yeon-Kyung Choi, Bong-Soo Cha, Dae Ho Lee
Diabetes & Metabolism Journal.2020; 44(3): 382. CrossRef Sarcopenia: an emerging risk factor for non-alcoholic fatty liver disease
Yong-ho Lee, Seung Up Kim
Hepatology International.2020; 14(1): 5. CrossRef Association between Non-Alcoholic Steatohepatitis and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus
Hokyou Lee, Gyuri Kim, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee, Kap Bum Huh
Diabetes & Metabolism Journal.2020; 44(2): 267. CrossRef Ipragliflozin Additively Ameliorates Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Controlled with Metformin and Pioglitazone: A 24-Week Randomized Controlled Trial
Eugene Han, Yong-ho Lee, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha
Journal of Clinical Medicine.2020; 9(1): 259. CrossRef Non-alcoholic steatohepatitis and progression of carotid atherosclerosis in patients with type 2 diabetes: a Korean cohort study
Hyeok-Hee Lee, Yongin Cho, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Seok Won Park, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee, Kap Bum Huh
Cardiovascular Diabetology.2020;[Epub] CrossRef Hepatic fibrosis is associated with total proteinuria in Korean patients with type 2 diabetes
Eugene Han, Yongin Cho, Kyung-won Kim, Yong-ho Lee, Eun Seok Kang, Bong-Soo Cha, Byung-wan Lee
Medicine.2020; 99(33): e21038. CrossRef Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?
Min Zhang, Su Lin, Ming-fang Wang, Jiao-feng Huang, Shi-ying Liu, Su-mei Wu, Hao-yang Zhang, Zi-mu Wu, Wen-Yue Liu, Dong-Chu Zhang, Chuan-ming Hao, Yue-yong Zhu, Ming-Hua Zheng, Xiao-zhong Wang
BMC Gastroenterology.2020;[Epub] CrossRef Association Between Serum Bilirubin and the Progression of Carotid Atherosclerosis in Type 2 Diabetes
Inkuk Lee, Hyeok-Hee Lee, Yongin Cho, Young Ju Choi, Byung Wook Huh, Byung-Wan Lee, Eun Seok Kang, Seok Won Park, Bong-Soo Cha, Eun Jig Lee, Yong-ho Lee, Kap Bum Huh
Journal of Lipid and Atherosclerosis.2020; 9(1): 195. CrossRef Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38)
Chan-Hee Jung
Journal of Obesity & Metabolic Syndrome.2020; 29(2): 158. CrossRef Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview
Niki Katsiki, Anca Pantea Stoian, Paschalis Steiropoulos, Nikolaos Papanas, Andra-Iulia Suceveanu, Dimitri P. Mikhailidis
Metabolites.2020; 10(11): 465. CrossRef Heart Failure and Liver Disease
Andrew Xanthopoulos, Randall C. Starling, Takeshi Kitai, Filippos Triposkiadis
JACC: Heart Failure.2019; 7(2): 87. CrossRef Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients
Asieh Mansour, Mohammad Reza Mohajeri-Tehrani, Majid Samadi, Hadis Gerami, Mostafa Qorbani, Nick Bellissimo, Hossein Poustchi, Azita Hekmatdoost
Acta Diabetologica.2019; 56(11): 1199. CrossRef Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model
Jae-Sung Ryu, Minji Lee, Seon Ju Mun, Sin-Hyoung Hong, Ho-Joon Lee, Hyo-Suk Ahn, Kyung-Sook Chung, Gun-Hwa Kim, Myung Jin Son
Journal of Biological Engineering.2019;[Epub] CrossRef Non-alcoholic steatohepatitis and type 2 diabetes mellitus: the effects of weight loss versus drug treatment
Niki Katsiki, Vasilios G Athyros
Current Medical Research and Opinion.2019; 35(7): 1305. CrossRef Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
Yong-ho Lee, Yongin Cho, Byung-Wan Lee, Cheol-Young Park, Dae Ho Lee, Bong-Soo Cha, Eun-Jung Rhee
Diabetes & Metabolism Journal.2019; 43(1): 31. CrossRef Progress in the Study of the Pathogenesis of Chronic Kidney Disease Associated with Nonalcoholic Fatty Liver Disease
清莲 宋
Advances in Clinical Medicine.2019; 09(09): 1073. CrossRef Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study
You‐Cheol Hwang, Hong‐Yup Ahn, Cheol‐Young Park
Obesity.2019; 27(8): 1360. CrossRef Subfornical organ insulin receptors tonically modulate cardiovascular and metabolic function
Jin Kwon Jeong, Julie A. Horwath, Hayk Simonyan, Katherine A. Blackmore, Scott D. Butler, Colin N. Young
Physiological Genomics.2019; 51(8): 333. CrossRef Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
Kyung-Soo Kim, Byung-Wan Lee, Yong Jin Kim, Dae Ho Lee, Bong-Soo Cha, Cheol-Young Park
Diabetes & Metabolism Journal.2019; 43(2): 127. CrossRef Chicken Protein Hydrolysates Have Anti-Inflammatory Effects on High-Fat Diet Induced Obesity in Mice
Thomas Aloysius, Ana Carvajal, Rasa Slizyte, Jon Skorve, Rolf Berge, Bodil Bjørndal
Medicines.2018; 6(1): 5. CrossRef STK25 Regulates Cardiovascular Disease Progression in a Mouse Model of Hypercholesterolemia
Emmelie Cansby, Elin Magnusson, Esther Nuñez-Durán, Manoj Amrutkar, Matteo Pedrelli, Paolo Parini, Jenny Hoffmann, Marcus Ståhlman, Brian W. Howell, Hanns-Ulrich Marschall, Jan Borén, Margit Mahlapuu
Arteriosclerosis, Thrombosis, and Vascular Biology.2018; 38(8): 1723. CrossRef Organ-Specific Mechanisms of Transendothelial Neutrophil Migration in the Lung, Liver, Kidney, and Aorta
Sanne L. Maas, Oliver Soehnlein, Joana R. Viola
Frontiers in Immunology.2018;[Epub] CrossRef Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up
Chaonan Xu, Zhimin Ma, Yunfeng Wang, Xiangtong Liu, Lixin Tao, Deqiang Zheng, Xiuhua Guo, Xinghua Yang
Liver International.2018; 38(12): 2294. CrossRef Obesity induced alterations in redox homeostasis and oxidative stress are present from an early age
Alfonso M. Lechuga-Sancho, David Gallego-Andujar, Pablo Ruiz-Ocaña, Francisco M. Visiedo, Ana Saez-Benito, Mónica Schwarz, Carmen Segundo, Rosa M. Mateos, Manuel Portero-Otin
PLOS ONE.2018; 13(1): e0191547. CrossRef Capybara Oil Improves Hepatic Mitochondrial Dysfunction, Steatosis, and Inflammation in a Murine Model of Nonalcoholic Fatty Liver Disease
Polyana C. Marinho, Aline B. Vieira, Priscila G. Pereira, Kíssila Rabelo, Bianca T. Ciambarella, Ana L. R. Nascimento, Erika Cortez, Aníbal S. Moura, Fernanda V. Guimarães, Marco A. Martins, Gonzalo Barquero, Rodrigo N. Ferreira, Jorge J. de Carvalho
Evidence-Based Complementary and Alternative Medicine.2018; 2018: 1. CrossRef Persistently Increased Resting Energy Expenditure Predicts Short-Term Mortality in Patients with Acute-on-Chronic Liver Failure
Jia Yao, Xiaoshuang Zhou, Hui Wang, Lili Yuan, Yu Chen, Zhongping Duan
Annals of Nutrition and Metabolism.2018; 73(1): 2. CrossRef The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice
Dong Wang, Yuhuan Luo, Xiaoxin Wang, David Orlicky, Komuraiah Myakala, Pengyuan Yang, Moshe Levi
International Journal of Molecular Sciences.2018; 19(1): 137. CrossRef Association of sex hormone-binding globulin with nonalcoholic fatty liver disease in Chinese adults
Jing Luo, Qian Chen, Tianran Shen, Xu Wang, Wanjun Fang, Xiaocai Wu, Zenan Yuan, Gengdong Chen, Wenhua Ling, Yuming Chen
Nutrition & Metabolism.2018;[Epub] CrossRef
|